Leerink Partners Reiterates Outperform Rating on Biohaven Pharma (BHVN), lowers EPS estimates
Go back to Leerink Partners Reiterates Outperform Rating on Biohaven Pharma (BHVN), lowers EPS estimates| (NYSE: BHVN) | Delayed: 11.40 +0.59 (5.46%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.81 | 52 Week High | $ | |||
| Open | $10.90 | 52 Week Low | $ | |||
| Day High | $11.43 | P/E | N/A | |||
| Day Low | $10.76 | EPS | $ | |||
| Volume | 3,427,020 | |||||
